<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01632059</url>
  </required_header>
  <id_info>
    <org_study_id>ADSeS (PV3927)</org_study_id>
    <nct_id>NCT01632059</nct_id>
  </id_info>
  <brief_title>Examination of ADMA Serum Level and DDAH II</brief_title>
  <acronym>ADSeS</acronym>
  <official_title>Examination of ADMA (Asymmetric-dimethylarginine)-Serum Level and DDAH II (Dimethylarginine Dimethylaminohydrolase)- Polymorphism in Patients With Severe Sepsis and Septic Shock as Prognostic Value</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examination of ADMA (Asymmetric-Dimethylarginine)-serum level and DDAH II (Dimethylarginine
      Dimethylaminohydrolase)- Polymorphism in patients with severe Sepsis and septic shock as
      prognostic value.

      This study looks into ADMA as a good prognostic factor for sepsis. Further more the
      dependency of the ADMA level to the DDAH II polymorphisms is reviewed this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary targets are the mortality (28 days ICU), the length of hospitalisation in ICU and
      peripheral station, the severity of the illness (SAPS II score), the SOFA-score values in the
      progress and the procalcitonin values in the progress
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ADMA serum levels</measure>
    <time_frame>7 days</time_frame>
    <description>measuring of ADMA serum levels on day 1, 3, 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>28 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalisation (ICU and peripheral)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>severity of illness</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DDAH Ii polymorphism</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Septic Shock</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>septical patients</arm_group_label>
    <description>inclusion criteria are severe sepsis and septical shock and must be &gt; 18 y/o</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients &gt; 18 y/o with sepsis and/or septical shock
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 y/o

          -  sepsis

          -  septical shock

        Exclusion Criteria:

          -  primary cardiogenic shock

          -  pregnancy

          -  breastfeeding

          -  non compliance

          -  moribund status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Kluge, Priv.-Doz.</last_name>
    <role>Study Director</role>
    <affiliation>Director of critical care center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätskrankenhaus Hamburg Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uke.uni-hamburg.de</url>
    <description>Related Info</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2012</study_first_submitted>
  <study_first_submitted_qc>June 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2012</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ADMA</keyword>
  <keyword>DDAH II</keyword>
  <keyword>SAPS</keyword>
  <keyword>SOFA</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Procalcitonin</keyword>
  <keyword>ICU</keyword>
  <keyword>mortality</keyword>
  <keyword>length of stay</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

